Michael Jarjour, MBA

Michael Jarjour is a senior health care executive with 20+ years of experience steering organizations to new heights of innovation and profitability. His extensive background in commercialization—and expertise in developing novel health care technologies and the vision, teams, infrastructures, and budgets to support them—has increased value in both “big pharma” and healthcare technology environments.

Working at the intersection of strategic vision and practical execution, Michael has delivered industry-changing technologies and achieved rapid, sustained growth. He recruits top talent, builds robust organizations, and facilitates all stages of commercialization to make a powerful impact on patients’ lives, improving health care delivery, accessibility, and outcomes.

Over the course of his career, Michael has broken new ground in novel health care technology (with digital technology, AI, machine learning at the forefront), revenue-generating commercialization (digital solutions as well as early-development and non-promoted, late-stage pharmaceutical products), and fundraising (to jumpstart and scale organizations). He attributes his success to the determination, expertise, and hard work of his teams, as well as an ability to monitor ever-emerging opportunities and key trends in health care innovation and respond accordingly. Michael held key positions at Steward Health Care, Pfizer, Otsuka, Organon, Bristol-Myers Squibb, Pharmacia, Warner Lambert and Wyeth. Prior to joining Steward he was CEO of a population health company focused on behavioral health. Michael received his undergraduate degree in Finance from Florida International University and his MBA from Rutgers University.

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.